Sugi Predict

Sugi Predict / Compounds / SCHEMBL10072557

SCHEMBL10072557

SCHEMBL10072557

Cc1ccc2c(c1)sc1c3ccccc3sc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.50
▸ ALDH1A1 P00352 5/20 0.46
▸ RAB9A P51151 5/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ HPGD P15428 1/20 0.46
▸ GPR3 P46089 1/20 0.44
▸ L3MBTL1 Q9Y468 4/20 0.42
▸ LMNA P02545 2/20 0.42
▸ HCRTR1 O43613 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ KDM4E B2RXH2 2/20 0.41
▸ ATM Q13315 1/20 0.41
▸ KIF11 P52732 1/20 0.41
▸ BCL2L1 Q07817 1/20 0.41
▸ MCL1 Q07820 1/20 0.41
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ TNKS O95271 1/20 0.40
▸ TNKS2 Q9H2K2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18760469 0.96 MAPT (0.47) MAPTALDH1A1RAB9ASMN1; SMN2HPGD
SCHEMBL22902217 0.90 MAPT (0.53) MAPTALDH1A1RAB9ASMN1; SMN2HPGD
SCHEMBL3123994 0.89 BCL2L1 (0.47) MAPTALDH1A1RAB9ASMN1; SMN2HPGD
SCHEMBL808361 0.88 GPR3 (0.61) MAPTALDH1A1RAB9ASMN1; SMN2HPGD
SCHEMBL31677946 0.88 GPR3 (0.61) MAPTALDH1A1RAB9ASMN1; SMN2HPGD
SCHEMBL17037059 0.86 BCL2L1 (0.42) MAPTALDH1A1RAB9ASMN1; SMN2HPGD
SCHEMBL23046392 0.85 TNKS (0.46) MAPTALDH1A1RAB9ASMN1; SMN2HPGD
SCHEMBL26325344 0.85 TNKS (0.46) MAPTALDH1A1RAB9ASMN1; SMN2HPGD
SCHEMBL12687983 0.85 TNKS (0.46) MAPTALDH1A1RAB9ASMN1; SMN2HPGD
SCHEMBL11892121 0.85 BCL2L1 (0.44) MAPTRAB9ASMN1; SMN2LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11800784-B2 Two-dimensional halide perovskite materials PURDUE RESEARCH FOUNDATION (US) 2023-10-24 — — US disclosed
US-11800784-B2 Two-dimensional halide perovskite materials PURDUE RESEARCH FOUNDATION (US) 2023-10-24 — — US disclosed
US-11667650-B2 Thieno-indeno-monomers and polymers CLAP CO., LTD. (KR) 2023-06-06 — — US disclosed
US-11667650-B2 Thieno-indeno-monomers and polymers CLAP CO., LTD. (KR) 2023-06-06 — — US disclosed
US-11384197-B2 Semiconductors CLAP CO., LTD. (KR) 2022-07-12 — — US disclosed
US-20220041617-A1 THIENO-INDENO-MONOMERS AND POLYMERS BASF SE (DE) 2022-02-10 — — US disclosed
US-11225489-B2 Thieno-indeno-monomers and polymers BASF SE (DE) 2022-01-18 — — US disclosed
US-11198698-B2 Organic semiconductor composition, organic thin film comprising same, and use thereof NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2021-12-14 — — US disclosed
US-20210343948-A1 Two-Dimensional Halide Perovskite Materials PURDUE RESEARCH FOUNDATION (US) 2021-11-04 — — US disclosed
EP-3423455-B1 SEMICONDUCTING POLYMER CLAP CO LTD (KR) 2021-06-23 — — EP disclosed
US-20140350642-A1 Metal Complexes Comprising 1,2,3-Triazoles MERCK PATENT GMBH (DE) 2014-11-27 — — US disclosed
WO-2013174471-A1 METAL COMPLEXES COMPRISING CONDENSED HETEROAROMATIC RINGS MERCK PATENT GMBH (DE) 2013-11-28 — — WO disclosed
WO-2013107487-A1 ORGANIC METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-07-25 — — WO disclosed
WO-2013097920-A1 METAL COMPLEXES COMPRISING 1,2,3-TRIAZOLES MERCK PATENT GMBH (DE) 2013-07-04 — — WO disclosed
WO-2013087162-A1 ORGANIC SENSITIZERS FOR UP-CONVERSION MERCK PATENT GMBH (DE) 2013-06-20 — — WO disclosed
WO-2012010292-A1 SEMICONDUCTORS BASED ON SUBSTITUTED [1]BENZOTHIENO[3,2-b] [1]-BENZOTHIOPHENES HERAEUS CLEVIOS GMBH (DE) 2012-01-26 — — WO disclosed
US-7976959-B2 Organic electroluminescent element including bibenzothiopene containing organic compound and display device including the same FUJI XEROX CO., LTD. (JP) 2011-07-12 — — US disclosed
US-7976959-B2 Organic electroluminescent element including bibenzothiopene containing organic compound and display device including the same FUJI XEROX CO., LTD. (JP) 2011-07-12 — — US disclosed
US-20090243469-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND DISPLAY DEVICE INCLUDING THE SAME FUJI XEROX CO., LTD. (JP) 2009-10-01 — — US disclosed
US-20090243469-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND DISPLAY DEVICE INCLUDING THE SAME FUJI XEROX CO., LTD. (JP) 2009-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667650-B2 Thieno-indeno-monomers and polymers RPS21, OXER1, OXSR1 MAPT 3081/4885ALDH1A1 2559/4885RAB9A 4603/4885
US-20220041617-A1 THIENO-INDENO-MONOMERS AND POLYMERS RPS21, OXER1, OXSR1 MAPT 3081/4885ALDH1A1 2559/4885RAB9A 4603/4885
US-20210343948-A1 Two-Dimensional Halide Perovskite Materials EYA2, BRAP, EYA3 MAPT 2061/4885ALDH1A1 2678/4885RAB9A 330/4885
US-11225489-B2 Thieno-indeno-monomers and polymers TERT, TERB1, TERF2 MAPT 126/4885ALDH1A1 122/4885RAB9A 1861/4885
US-11198698-B2 Organic semiconductor composition, organic thin film comprising same, and use thereof TST, TRMT1, OR10J3 MAPT 1530/4885ALDH1A1 1350/4885RAB9A 3237/4885
US-11800784-B2 Two-dimensional halide perovskite materials EYA2, BRAP, EYA3 MAPT 2061/4885ALDH1A1 2678/4885RAB9A 330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.